Next generation sequencing and peripheral blood ctdna testing services (RESEARCH)

Active Indefinite Delivery Contract Awarded Last action

Contract number
36C24E25D0014
Awardee
Awarding agency
Task orders
2 $108,500 obligated

Award facts

Opportunity
Combined order value
$108,500 Current and potential, with all options
Last date to order 83% complete
IDV ceiling 74% used
$147,080.00
Maximum order
$73,500.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Veterans Integrated Service Network 10 Veterans Health Administration, Department of Veterans Affairs
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Natera Inc. has been awarded an Indefinite Delivery Contract by the Department of Veterans Affairs, Veterans Integrated Service Network 10, valued at $147,080 with an ultimate completion date of March 2, 2027. The contract is a non-set-aside, single award vehicle for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services supporting cancer research initiatives across VA medical centers. The prime contractor will deliver advanced genomic analysis services utilizing its proprietary Signatera assay platform, which provides highly sensitive and personalized ctDNA detection capabilities. Natera was selected as the sole source provider based on its specialized testing platforms, extensive validation record exceeding 100 peer-reviewed publications, and established relationship with the VA's National Precision Oncology Program.

The associated task order, awarded on March 3, 2025, provides $35,000 in firm fixed-price compensation for delivery by March 2, 2026, with performance taking place in Austin, Texas. This initial delivery order supports the RIVAL research study, which evaluates whether ctDNA clearance can predict progression-free survival in veterans with locally advanced non-small cell lung cancer across seven VA medical centers. The scope includes circulating tumor DNA analysis on approximately 40 samples from 20 patients at two time points following chemotherapy and immunotherapy treatment. The Signatera assay platform utilized under this contract is accredited by the College of American Pathologists and certified under the Clinical Laboratory Improvement Amendments, ensuring compliance with applicable quality and regulatory standards for clinical laboratory testing.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 36C24E25D0014?

36C24E25D0014 was awarded to Natera Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on March 3, 2025.

How much is contract 36C24E25D0014 worth?

Orders under 36C24E25D0014 have obligated $108,500. 36C24E25D0014's own ceiling is $147,080. A single order can be worth up to $73,500.

How many orders have been placed under contract 36C24E25D0014?

2 orders have been placed under 36C24E25D0014, the latest on March 3, 2026.

Which agency awarded contract 36C24E25D0014?

Veterans Integrated Service Network 4 (Veterans Health Administration) awarded 36C24E25D0014, with funding from Veterans Integrated Service Network 10 (Veterans Health Administration).

Who can order from contract 36C24E25D0014?

36C24E25D0014 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36C24E25D0014 competed?

The extent of competition for 36C24E25D0014 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV